Supplemental material
Scandinavian Journal of Gastroenterology
Volume 54, 2019 - Issue 10
Original Article
Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis
Mi Na KimDepartment of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea; 
http://orcid.org/0000-0001-5381-230XView further author information
http://orcid.org/0000-0001-5381-230XView further author information, , , , , & show allReprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Management of hepatocellular in the United States
Source:
AME Publishing Company
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
Source:
Elsevier BV
Globocan 2012
Source:
Wiley
Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey
Source:
Ovid Technologies (Wolters Kluwer Health)
Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis
Source:
Taylor & Francis
Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis
Source:
Taylor & Francis
NASH: A global health problem
Source:
Wiley-Blackwell
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
Source:
Elsevier BV
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Source:
Georg Thieme Verlag KG
The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers
Source:
American Association for Cancer Research (AACR)
Management of hepatocellular carcinoma: An update
Source:
Wiley
NJEI ET AL.
Source:
Wiley
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
Source:
Ovid Technologies (Wolters Kluwer Health)
Serological Surveillance for hepatocellular carcinoma: Time to quit
Source:
Elsevier BV
Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis
Source:
Wiley-Blackwell
Liver Transplantation for Hepatocellular Carcinoma
Source:
Ovid Technologies (Wolters Kluwer Health)
Surveillance for early diagnosis of hepatocellular carcinoma: How best to do it?
Source:
Baishideng Publishing Group Inc.
Elevated serum α-fetoprotein levels in patients with chronic hepatitis C virus genotype 4
Source:
Ovid Technologies (Wolters Kluwer Health)
A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
Source:
The Korean Association for the Study of the Liver
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.
Source:
Wiley
Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands
Source:
Elsevier BV
Alpha-fetoprotein: A biomarker for the recruitment of progenitor cells in the liver in patients with acute liver injury or failure
Source:
Wiley-Blackwell
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status
Source:
Elsevier BV
Hepatocellular Carcinoma Screening Practices in the Department of Veterans Affairs: Findings from a National Facility Survey
Source:
Springer Nature
Hepatocellular Carcinoma Surveillance: A National Survey of Current Practices in the USA
Source:
Springer Nature
Factors That Affect Efficacy of Ultrasound Surveillance for Early Stage Hepatocellular Carcinoma in Patients With Cirrhosis
Source:
Elsevier BV
Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.
Source:
American Association for Cancer Research (AACR)
Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm
Source:
Elsevier BV
Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
Source:
Ovid Technologies (Wolters Kluwer Health)
α-Fetoprotein for Hepatocellular Carcinoma Diagnosis: The Demise of a Brilliant Star
Source:
Elsevier BV
Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
Source:
The Korean Association for the Study of the Liver
Linking provided by
